October 1, 2015 9:57 AM | 2 min read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Analysts at Citigroup initiated coverage on
Qorvo Inc (NASDAQ: QRVO) with a Neutral rating. Qorvo shares closed at $45.05 on Wednesday. Analysts at RBC Capital initiated coverage on
Photronics, Inc. (NASDAQ: PLAB) with a Buy rating. The target price for Photronics is set to $12. Photronics shares closed at $9.06 on Wednesday.Analysts at Baird initiated coverage on
SPX Flow Inc (NYSE: FLOW) with a Outperform rating. The target price for SPX Flow is set to $40. SPX Flow shares closed at $34.43 on Wednesday. Analysts at Mizuho Securities initiated initiated coverage on
Kindred Healthcare, Inc. (NYSE: KND) with a Neutral rating. The target price for Kindred Healthcare is set to $16.75. Kindred Healthcare shares closed at $15.75 on Wednesday. Analysts at Citigroup initiated coverage of
Skyworks Solutions Inc (NASDAQ: SWKS) with a Buy rating. Skyworks Solutions shares closed at $84.07 on Wednesday.RBC Capital initiated coverage on
SPX Flow Inc (NYSE: FLOW) with a Underperform rating. The target price for SPX Flow is set to $32. SPX Flow shares closed at $34.43 on Wednesday.Sidoti & Co. initiated coverage of
Nuveen Build America Bond Opp Fund (NYSE: NBD) with a Buy rating. The target price for Nuveen Build America Bond Opp Fund is set to $43. Nuveen Build America Bond Opp Fund shares closed at $19.42 on Wednesday.Analysts at H.C. Wainwright initiated coverage of
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) with a Buy rating. The target price for Synergy Pharmaceuticals is set to $20. Synergy Pharmaceuticals shares closed at $5.28 on Wednesday.Compass Point initiated coverage on
First Niagara Financial Group Inc. (NASDAQ: FNFG) with a Buy rating. The target price for First Niagara Financial is set to $12. First Niagara Financial shares closed at $10.21 on Wednesday.Analysts at H.C. Wainwright initiated coverage on
Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) with a Buy rating. The target price for Oramed Pharmaceuticals is set to $24. Oramed Pharmaceuticals shares closed at $5.47 on Wednesday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.